Medpace Holdings MEDP
NASDAQ MEDP
$615.11 -1.33 (-0.22%)
As of: Sep 17, 2026 · 3:59 PM EDT

Medpace Holdings (MEDP) Interest & Investment Income (2015 - 2026)

Medpace Holdings' (MEDP) quarterly Interest & Investment Income came in at $5.0 million in Q2 2026, up 362.52% on a YoY basis from $1.1 million in Q2 2025, and down 2.56% quarter-over-quarter from $5.1 million in Q1 2026.

Analysis

Medpace Holdings (MEDP) Interest & Investment Income (2015 - 2026) Analysis & Trends

Medpace Holdings (MEDP) has reported Interest & Investment Income for 12 consecutive years, with $5.0 million the latest figure, recorded in Q2 2026.

  • For the quarter ending Q2 2026, Interest & Investment Income rose 362.52% year-over-year to $5.0 million; the trailing twelve-month figure through Jun 2026 stood at $15.3 million (down 33.16% YoY), and the FY2025 full-year result was $12.8 million, down 48.87% from the prior year.
  • Interest & Investment Income declined to $5.0 million in Q2 2026 per MEDP's latest filing, from $5.1 million in the prior quarter.
  • Across five years, Interest & Investment Income topped out at $7.9 million in Q4 2024 and bottomed at -$1.6 million in Q3 2022.
  • Historically, Interest & Investment Income has averaged $2.5 million across 5 years, with a median of $1.7 million in 2023.
  • The sharpest annual moves came in 2022 and 2024: Interest & Investment Income slumped 3763.41% in 2022, then jumped 7269.52% in 2024.
  • Over 5 years, Interest & Investment Income stood at -$827000.0 in 2022, then jumped by 322.97% to $1.8 million in 2023, then surged by 327.49% to $7.9 million in 2024, then slumped by 52.78% to $3.7 million in 2025, then surged by 33.96% to $5.0 million in 2026.
  • According to Business Quant data, Interest & Investment Income over the past three periods registered $5.0 million, $5.1 million, and $3.7 million for Q2 2026, Q1 2026, and Q4 2025 respectively.
Peer Set

Peer Comparison

# Company Market Cap Enterprise Value Gross Profit (Qtr) Int & Inv Inc (Qtr)
1 Iqvia Holdings 44.72 Bn 42.64 Bn 1.44 Bn 7.00 Mn
2 Medpace Holdings 17.37 Bn 16.87 Bn 201.64 Mn 4.99 Mn
3 Icon 13.65 Bn 12.72 Bn 479.29 Mn 3.16 Mn
4 Charles River Laboratories International 13.13 Bn 12.94 Bn 452.07 Mn 1.03 Mn
5 Fortrea Holdings 1.89 Bn 1.72 Bn 139.20 Mn -19.30 Mn
6 Evotec SE 574.75 Mn 148.87 Mn - -
7 Ginkgo Bioworks Holdings 439.63 Mn 355.09 Mn 18.44 Mn -210,000.00
8 Champions Oncology 69.43 Mn 65.03 Mn 7.70 Mn -
9 MindWalk Holdings 51.76 Mn 46.29 Mn 1.61 Mn 12,909.62
10 VivoSim Labs 1.37 Mn 1.37 Mn - 28,000.00
Historic Data

Historic Data

Download Data
DateValue
Jun 30, 2026 4.99 Mn
Mar 31, 2026 5.12 Mn
Dec 31, 2025 3.72 Mn
Sep 30, 2025 1.52 Mn
Jun 30, 2025 1.08 Mn
Mar 31, 2025 6.46 Mn
Dec 31, 2024 7.88 Mn
Sep 30, 2024 7.53 Mn
Jun 30, 2024 5.47 Mn
Mar 31, 2024 4.12 Mn
Dec 31, 2023 1.84 Mn
Sep 30, 2023 -105,000.00
Jun 30, 2023 -1.37 Mn
Mar 31, 2023 -861,000.00
Dec 31, 2022 -827,000.00
Sep 30, 2022 -1.58 Mn
Jun 30, 2022 -548,000.00
Mar 31, 2022 54,000.00
Dec 31, 2021 -23,000.00
Sep 30, 2021 -41,000.00